Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gavaghan

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Nature|April 20, 1995
NIH drops reasonable pricing clauseH Gavaghan
Nature|October 6, 1994
Gene advisory group switches focus to ethical issuesH Gavaghan
Nature|February 9, 1995
NIH: in line with expectationsH Gavaghan
Nature|March 16, 1995
Gene therapy approval may be rocky road for industryH Gavaghan
Nature|March 23, 1995
NIH to review priorities in readiness for future cutsH Gavaghan
Nature|June 23, 1994
Trials 'must compete for new funds'H Gavaghan
Nature|July 21, 1994
Peer review: NIH urged to streamline bidsH Gavaghan
Nature|November 17, 1994
Researchers face delay in supplies of RU486H Gavaghan
Nature|November 24, 1994
NIH seeks bids for vector centres for gene therapyH Gavaghan
Nature|August 30, 2000
Mergers and acquisitions rock UK chemical industry infrastructureH Gavaghan
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Nature|April 20, 1995
NIH drops reasonable pricing clauseH Gavaghan
Nature|October 6, 1994
Gene advisory group switches focus to ethical issuesH Gavaghan
Nature|February 9, 1995
NIH: in line with expectationsH Gavaghan
Nature|March 16, 1995
Gene therapy approval may be rocky road for industryH Gavaghan
Nature|March 23, 1995
NIH to review priorities in readiness for future cutsH Gavaghan
Nature|June 23, 1994
Trials 'must compete for new funds'H Gavaghan
Nature|July 21, 1994
Peer review: NIH urged to streamline bidsH Gavaghan
Nature|November 17, 1994
Researchers face delay in supplies of RU486H Gavaghan
Nature|November 24, 1994
NIH seeks bids for vector centres for gene therapyH Gavaghan
Nature|August 30, 2000
Mergers and acquisitions rock UK chemical industry infrastructureH Gavaghan
Pageof 7